Macquarie Group LTD Opko Health, Inc. Transaction History

Macquarie Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.21 - $1.42 $5,452 - $6,398	4,506 New	4,506 $5,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.81 $5,911 - $9,177	-3,266 Reduced 31.96%	6,953 $19,000
Q4 2021 Feb 11, 2022	SELL	$3.52 - $5.15 $18,571 - $27,171	-5,276 Reduced 34.05%	10,219 $49,000
Q3 2021 Nov 12, 2021	SELL	$3.44 - $4.24 $23,127 - $28,505	-6,723 Reduced 30.26%	15,495 $57,000
Q2 2021 Aug 13, 2021	BUY	$3.33 - $4.55 $30,019 - $41,018	9,015 Added 68.28%	22,218 $90,000
Q1 2021 May 14, 2021	SELL	$4.19 - $5.99 $12,414 - $17,748	-2,963 Reduced 18.33%	13,203 $57,000
Q3 2020 Nov 13, 2020	BUY	$2.99 - $5.96 $7,176 - $14,304	2,400 Added 17.43%	16,166 $60,000
Q2 2020 Aug 11, 2020	BUY	$1.15 - $3.41 $15,830 - $46,942	13,766 New	13,766 $47,000

255

187M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.19B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.